Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
2025 · 4th Quarter (Oct 1 - Dec 31)
ACCENDRA HEALTH INC.
Filed by ACCENDRA HEALTH INC..
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- Not reported
- Expenses
- $240,000.00
- Registrant
- ACCENDRA HEALTH INC.
- Client
- ACCENDRA HEALTH INC.
- Filing UUID
- 995182a7-9f56-4b91-8e7f-7ded0115eb41
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Literal federal measure citations: H.R. 2005, S. 2951, H.R. 2902, S. 1406
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
FY 2026 Appropriations.
CHAMPVA medical supply reimbursement.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.